BeyondSpring (BYSI) Amortizatization of Intangibles (2019 - 2026)
BeyondSpring's (BYSI) quarterly Amortizatization of Intangibles came in at $194000.0 in Q2 2026, up 4.86% year-over-year from $185000.0 in Q2 2025, and up 1.04% quarter-over-quarter from $192000.0 in Q1 2026.
Powered by 
Analysis
BeyondSpring (BYSI) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
BeyondSpring has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $194000.0 for Q2 2026.
- In Q2 2026, Amortizatization of Intangibles rose 4.86% year-over-year to $194000.0; the TTM figure through Jun 2026 stood at $764000.0 (up 5.52% YoY), while the FY2025 annual figure was $747000.0, up 6.41% from the prior year.
- Amortizatization of Intangibles came in at $194000.0 for Q2 2026 at BeyondSpring, up from $192000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $194000.0 in Q2 2026 to a low of $173000.0 in Q1 2024.
- Average Amortizatization of Intangibles over 3 years is $183500.0, with a median of $184500.0 recorded in 2025.
- Year-over-year, Amortizatization of Intangibles increased 6.74% in 2025 and grew 4.35% in 2026.
- Over 3 years, Amortizatization of Intangibles stood at $178000.0 in 2024, then grew by 6.74% to $190000.0 in 2025, then rose by 2.11% to $194000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $194000.0 in Q2 2026, $192000.0 in Q1 2026, and $190000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 984.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 4.33 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 194,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 194,000.00 |
| Mar 31, 2026 | 192,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Sep 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Jun 30, 2024 | 174,000.00 |
| Mar 31, 2024 | 173,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 144,000.00 |
| Jun 30, 2021 | 123,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Dec 31, 2020 | 202,000.00 |
| Sep 30, 2020 | 161,000.00 |
| Jun 30, 2020 | 139,000.00 |
| Mar 31, 2020 | 157,000.00 |
| Dec 31, 2019 | 271,000.00 |
| Sep 30, 2019 | 119,000.00 |